Viora companion index
Drug companion guides
General lifestyle information for people starting GLP-1s and related weight-management medications. Not medical advice — always follow your prescriber's instructions.
Prescription medications
AOD-9604
A synthetic fragment of human growth hormone (hGH176-191) investigated for its potential effects on fat metabolism.
Open protocol →
BPC-157
Synthetic gastric-derived peptide investigated in regeneration and GI models.
Open protocol →
Cagrilintide
CagriSema (combination)
A long-acting amylin analogue under clinical investigation for weight management, including in combination with semaglutide.
Open protocol →
Liraglutide (Saxenda)
Saxenda
A GLP-1 receptor agonist prescribed for chronic weight management in adults and adolescents.
Open protocol →
Mazdutide
A dual GLP-1 / glucagon receptor agonist under clinical development for weight management and metabolic disease.
Open protocol →
Retatrutide
A triple receptor agonist (GLP-1, GIP, glucagon) in late-stage clinical development for obesity and metabolic disease.
Open protocol →
Semaglutide (Ozempic)
Ozempic
A GLP-1 receptor agonist primarily indicated for type 2 diabetes management, also prescribed off-label for weight management.
Open protocol →
Semaglutide (Wegovy)
Wegovy
A GLP-1 receptor agonist prescribed for chronic weight management in adults.
Open protocol →
Tirzepatide (Mounjaro)
Mounjaro
A dual GLP-1 / GIP receptor agonist prescribed for type 2 diabetes management.
Open protocol →
Tirzepatide (Zepbound)
Zepbound
A dual GLP-1 / GIP receptor agonist approved for chronic weight management.
Open protocol →